Association of Low Expression of Notch-1 and Jagged-1 in Human Papillary Bladder Cancer and Shorter Survival

Journal of Urology

Volumn 180, Issue 1, 2008, Pages 361-366

  Shi, Tao ping ^a   Xu, Hua ^a   Wei, Jian feng ^a   Ai, Xing ^a   Ma, Xin ^a   Wang, Bao jun ^a   Ju, Zheng hua ^a   Zhang, Guo xi ^a   Wang, Chao ^a   Wu, Zhen qi ^a   Zhang, Xu ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

carcinoma, transitional cell; mortality; Notch; receptors; signal transduction; urinary bladder

Indexed keywords

ANTINEOPLASTIC AGENT; DELTA LIKE 1; JAGGED1; LIGAND; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER EPITHELIUM; CANCER PATIENT; CANCER SURVIVAL; CELL LINE; CLINICAL STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PAPILLOMA; PATHOLOGY; POSTOPERATIVE PERIOD; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; UROTHELIUM; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; CALCIUM-BINDING PROTEINS; CARCINOMA, TRANSITIONAL CELL; CELL LINE; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROGNOSIS; RECEPTOR, NOTCH1; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 44649129124     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.02.037     Document Type: Article

References (20)

1. Michaud D.S., Spiegelman D., Clinton S.K., Rimm E.B., Willett W.C., and Giovannucci E. Prospective study of dietary supplements, macronutrients, micronutrients, and risk of bladder cancer in US men. Am J Epidemiol 152 (2000) 1145
2. Jebar A.H., Hurst C.D., Tomlinson D.C., Johnston C., Taylor C.F., and Knowles M.A. FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma. Oncogene 24 (2005) 5218
3. Chatterjee S.J., Datar R., Youssefzadeh D., George B., Goebell P.J., Stein J.P., et al. Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma. J Clin Oncol 22 (2004) 1007
4. Malats N., Bustos A., Nascimento C.M., Fernandez F., Rivas M., Puente D., et al. P53 as a prognostic marker for bladder cancer: a meta-analysis and review. Lancet Oncol 6 (2005) 678
5. Thievessen I., Seifert H.H., Swiatkowski S., Florl A.R., and Schulz W.A. E-cadherin involved in inactivation of WNT/beta-catenin signalling in urothelial carcinoma and normal urothelial cells. Br J Cancer 88 (2003) 1932
6. Hayward P., Brennan K., Sanders P., Balayo T., DasGupta R., Perrimon N., et al. Notch modulates Wnt signalling by associating with Armadillo/beta-catenin and regulating its transcriptional activity. Development 132 (2005) 1819
7. Rangarajan A., Talora C., Okuyama R., Nicolas M., Mammucari C., Oh H., et al. Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J 20 (2001) 3427
8. Bray S.J. Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 7 (2006) 678
9. Ellisen L.W., Bird J., West D.C., Soreng A.L., Reynolds T.C., Smith S.D., et al. TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 66 (1991) 649
10. Sobin L.H., and Wittekind C. TNM Classification of Malignant Tumors. 5th ed. (1997), Wiley-Liss, New York
11. Patel N.S., Dobbie M.S., Rochester M., Steers G., Poulsom R., Le Monnier K., et al. Up-regulation of endothelial delta-like 4 expression correlates with vessel maturation in bladder cancer. Clin Cancer Res 12 (2006) 4836
12. Villa N., Walker L., Lindsell C.E., Gasson J., Iruela-Arispe M.L., and Weinmaster G. Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. Mech Dev 108 (2001) 161
13. Dinse G.E., and Lagakos S.W. Nonparametric estimation of lifetime and disease onset distributions from incomplete observations. Biometrics 38 (1982) 921
14. Gill R.D. Multistate life-tables and regression models. Math Populat Stud 3 (1992) 259
15. Nickoloff B.J., Qin J.Z., Chaturvedi V., Denning M.F., Bonish B., and Miele L. Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-kappaB and PPARgamma. Cell Death Differ 9 (2002) 842
16. Talora C., Sgroi D.C., Crum C.P., and Dotto G.P. Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation. Genes Dev 16 (2002) 2252
17. Zagouras P., Stifani S., Blaumueller C.M., Carcangiu M.L., and Artavanis-Tsakonas S. Alterations in Notch signaling in neoplastic lesions of the human cervix. Proc Natl Acad Sci U S A 92 (1995) 6414
18. Gray G.E., Mann R.S., Mitsiadis E., Henrique D., Carcangiu M.L., Banks A., et al. Human ligands of the Notch receptor. Am J Pathol 154 (1999) 785
19. Jaleco A.C., Neves H., Hooijberg E., Gameiro P., Clode N., Haury M., et al. Differential effects of Notch ligands Delta-1 and Jagged-1 in human lymphoid differentiation. J Exp Med 194 (2001) 991
20. Schmitt T.M., and Zuniga-Pflucker J.C. Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 17 (2002) 749